Introduction: Quality of Life Abstracts from the Dia Fourth Annual Symposium of Contributed Papers on Quality of Life Ev
- PDF / 75,170 Bytes
- 1 Pages / 504 x 720.24 pts Page_size
- 52 Downloads / 159 Views
0092-8615l97 Copyright 0 1997 Drug Information Association Inc.
INTRODUCTION: QUALITY OF LIFE ABSTRACTS FROM THE DIA FOURTH ANNUAL SYMPOSIUM OF CONTRIBUTED PAPERS ON QUALITY OF LIFE EVALUATION FAYEA. LUSCOMBE
5
-‘ 4
Pegasus, kchland, Michqan
ROBERTS. EPSTEIN
5ri’
5
Merck-Medco Managed Care, L.L.C., Montvale. New Jersey
EVA LYDICK
4“( = - )
SmthKline Beecham Pharmaceuhcals, Collegeville, Pennsylvama
THE FOURTH ANNUAL symposium of contributed papers on quality of life evaluation was held in Charleston, South Carolina, on May 12-13,1997. This exchange of information on quality of life evaluation included some of the most innovative thinkers in the field of health related-quality of life (QOL) research and performance measurement. The theme of the plenary session was “Quality of Life in Medical Practice.” Speakers represented the disease management community, managed care, the National Committee on Quality Assurance, and the Agency for Health Cape Policy and Research. These differing perspectives resulted in a stimulating and lively discussion on the status and future of QOL in medical care. The remaining oral presentations and the posters were selected through a blinded peer review process from abstracts submitted by researchers in the field of QOL. A total of 19 papers were selected for oral presentation along with approximately 50 abstracts. Presenters were from the United States, Canada,
and Europe. They represented government, accrediting agencies, medical care settings and research institutions, disease management companies, academia, the pharmaceutical industry, contract research organizations, and clinical research institutions. Contributed papers were grouped into sessions of “Development, Validation and Interpretation of QOL,” “QOL in Observational Studies,” and “QOL in Intervention Trials.” A new session, “Quality of Life in Medical Care,” provided the opportunity to hear examples of QOL measurement in medical care settings. Also, for the first time in the history of these annual QOL symposia, a contributed workshop was featured entitled “Broadening the Role of Psychometric Analysis in Quality of Life Assessment.” The program committee gratefully acknowledges the contributions of all participants, session chairs, and peer reviewers and is pleased to include the abstracts for both the oral and the poster presentations in this issue of the journal.
Reprint address: Dr. Eva Lydick, Director, Epiderniology. SmithKline Beecham Pharmaceuticals, 1250 South Collegeville Road, UP4205, Collegeville, PA 194260989. Downloaded from dij.sagepub.com at Karolinska Institutets Universitetsbibliotek on May 24, 2015
1405
Data Loading...
